CD274 and cancer: Kadara et al. had examined early stages LUACs and discovered that tumors with STK11 mutations exhibited relatively low levels of infiltrating CD4+/CD8+ T-cells and, again, TP53-mutant cancers showed elevated PD-L1 TPS [52].